These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 22085390)

  • 1. Low-dose topiramate plus sodium divalproate for positive responders intolerant to full-dose monotherapy.
    Krymchantowski AV; Jevoux Cda C
    Headache; 2012 Jan; 52(1):129-32. PubMed ID: 22085390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topiramate vs divalproex sodium in the preventive treatment of migraine: a prospective "real-world" study.
    Krymchantowski AV; Jevoux CC
    Headache; 2011 Apr; 51(4):554-8. PubMed ID: 21457240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topiramate in migraine prophylaxis: long-term impact on resource utilization and cost.
    Silberstein SD; Feliu AL; Rupnow MF; Blount AC; Boccuzzi SJ
    Headache; 2007 Apr; 47(4):500-10. PubMed ID: 17445099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conversion from valproic acid onto topiramate in adolescents and adults with epilepsy.
    Schreiner A; Stollhoff K; Ossig W; Unkelbach S; Lüer W; Bogdanow M; Schauble B;
    Acta Neurol Scand; 2009 May; 119(5):304-12. PubMed ID: 19133865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topiramate in migraine prophylaxis: a randomised double-blind versus placebo study.
    Mei D; Capuano A; Vollono C; Evangelista M; Ferraro D; Tonali P; Di Trapani G
    Neurol Sci; 2004 Dec; 25(5):245-50. PubMed ID: 15624081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of open-label topiramate as primary or adjunctive therapy in infantile spasms.
    Zou LP; Lin Q; Qin J; Cai FC; Liu ZS; Mix E;
    Clin Neuropharmacol; 2008; 31(2):86-92. PubMed ID: 18382180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topiramate and triptans revert chronic migraine with medication overuse to episodic migraine.
    Mei D; Ferraro D; Zelano G; Capuano A; Vollono C; Gabriele C; Di Trapani G
    Clin Neuropharmacol; 2006; 29(5):269-75. PubMed ID: 16960472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistence with migraine prophylactic treatment and acute migraine medication utilization in the managed care setting.
    Yaldo AZ; Wertz DA; Rupnow MF; Quimbo RM
    Clin Ther; 2008 Dec; 30(12):2452-60. PubMed ID: 19167603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of the effects of low-dose topiramate versus sodium valproate in migraine prophylaxis.
    Afshari D; Rafizadeh S; Rezaei M
    Int J Neurosci; 2012 Feb; 122(2):60-8. PubMed ID: 21950578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiepileptic drugs in the prophylaxis of migraine, chronic headache forms and cluster headache: a review of their efficacy and tolerability.
    D'Amico D
    Neurol Sci; 2007 May; 28 Suppl 2():S188-97. PubMed ID: 17508169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topiramate for migraine prevention in a naturalistic setting: results from an open label, flexible dose study.
    Nelles G; Delbrück A; Schulze L; Kademann B; Bornhoevd K; Schäfer S; Schäuble B;
    Headache; 2009; 49(10):1454-65. PubMed ID: 19804392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zonisamide versus topiramate in migraine prophylaxis: a double-blind randomized clinical trial.
    Mohammadianinejad SE; Abbasi V; Sajedi SA; Majdinasab N; Abdollahi F; Hajmanouchehri R; Faraji A
    Clin Neuropharmacol; 2011; 34(4):174-7. PubMed ID: 21738025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Divalproex sodium in the treatment of migraine and cluster headaches.
    Gallagher RM; Mueller LL; Freitag FG
    J Am Osteopath Assoc; 2002 Feb; 102(2):92-4. PubMed ID: 11866398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of topiramate on neurophysiological and neuropsychological tests in migraine patients.
    Kececi H; Atakay S
    J Clin Neurosci; 2009 Dec; 16(12):1588-91. PubMed ID: 19793661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effect of topiramate and sodium valporate in migraine prevention: a randomized blinded crossover study.
    Shaygannejad V; Janghorbani M; Ghorbani A; Ashtary F; Zakizade N; Nasr V
    Headache; 2006 Apr; 46(4):642-8. PubMed ID: 16643559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective study on the treatment of infantile spasms with first-line topiramate followed by low-dose ACTH.
    Zhu X; Chen O; Zhang D; Jin R; Li F; Wang Y; Sun R
    Epilepsy Res; 2011 Feb; 93(2-3):149-54. PubMed ID: 21205578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of a negative response to topiramate therapy in patients with chronic migraine.
    Rothrock JF; Parada VA; Drinkard R; Zweifler RM; Key KF
    Headache; 2005; 45(7):932-5. PubMed ID: 15985112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing the combination beta-blocker plus topiramate in refractory migraine.
    Pascual J; Rivas MT; Leira R
    Acta Neurol Scand; 2007 Feb; 115(2):81-3. PubMed ID: 17212609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term migraine prevention with topiramate: open-label extension of pivotal trials.
    Rapoport A; Mauskop A; Diener HC; Schwalen S; Pfeil J
    Headache; 2006; 46(7):1151-60. PubMed ID: 16866719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
    Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J;
    Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.